Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.35 and traded as high as $0.48. Cell MedX shares last traded at $0.48, with a volume of 1,590 shares.
Cell MedX Stock Up 0.5%
The business has a 50-day moving average of $0.35 and a 200-day moving average of $0.35.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Articles
- Five stocks we like better than Cell MedX
- How to start investing in penny stocks
- Monolithic Power Surges in 2025—Time to Buy or Hold?
- Earnings Per Share Calculator: How to Calculate EPS
- Tesla Has Been Trapped in a 10% Range for Months—What’s Going On?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
